{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:48:00Z","timestamp":1772804880090,"version":"3.50.1"},"reference-count":40,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2131\/jts.42.671","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T22:20:40Z","timestamp":1510784440000},"page":"671-681","source":"Crossref","is-referenced-by-count":9,"title":["Fish oil feeding reverses hepatomegaly and disrupted hepatic function due to the lack of FXR signaling"],"prefix":"10.2131","volume":"42","author":[{"given":"Masaaki","family":"Miyata","sequence":"first","affiliation":[{"name":"Department of Food Science and Technology, National Fisheries University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Shinno","sequence":"additional","affiliation":[{"name":"Department of Food Science and Technology, National Fisheries University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Food Science and Technology, National Fisheries University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Food Science and Technology, National Fisheries University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Food Science and Technology, National Fisheries University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","unstructured":"Bjursell, M., Wedin, M., Admyre, T., Hermansson, M., B\u00f6ttcher, G., G\u00f6ransson, M., Lind\u00e9n, D., Bamberg, K., Oscarsson, J. and Bohlooly, Y.M. (2013): Ageing Fxr defi cient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH. PLoS One, <b>8<\/b>, e64721."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Calder, P.C. (2012): Mechanisms of action of (n-3) fatty acids. J. Nutr., <b>142<\/b>, 592S-599S.","DOI":"10.3945\/jn.111.155259"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cohen, J.C., Horton, J.D. and Hobbs, H.H. (2011): Human fatty liver disease: old questions and new insights. Science, <b>332<\/b>, 1519-1523.","DOI":"10.1126\/science.1204265"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Delarue, J. and Lall\u00e8s, J.P. (2016): Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA. Mol. Nutr. Food Res., <b>60<\/b>, 147-159.","DOI":"10.1002\/mnfr.201500346"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Delarue, J., Li, C.H., Cohen, R., Corporeau, C. and Simon, B. (2006): Interaction of fi sh oil and a glucocorticoid on metabolic responses to an oral glucose load in healthy human subjects. Br. J. Nutr., <b>95<\/b>, 267-272.","DOI":"10.1079\/BJN20051631"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Di Minno, M.N., Russolillo, A., Lupoli, R., Ambrosino, P., Di Minno, A. and Tarantino, G. (2012): Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J. Gastroenterol., <b>18<\/b>, 5839-5847.","DOI":"10.3748\/wjg.v18.i41.5839"},{"key":"7","unstructured":"Ghosh, S. and Karin, M. (2002): Missing pieces in the NF-kappaB puzzle. Cell, <b>109 Suppl.<\/b>, S81-96."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C.L., McDonald, J.G., Luo, G., Jones, S.A., Goodwin, B., Richardson, J.A., Gerard, R.D., Repa, J.J., Mangelsdorf, D.J. and Kliewer, S.A. (2005): Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab., <b>2<\/b>, 217-225.","DOI":"10.1016\/j.cmet.2005.09.001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Jones, S. (2008): Mini-review: endocrine actions of fibroblast growth factor 19. Mol. Pharm., <b>5<\/b>, 42-48.","DOI":"10.1021\/mp700105z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Jump, D.B., Botolin, D., Wang, Y., Xu, J., Christian, B. and Demeure, O. (2005): Fatty acid regulation of hepatic gene transcription. J. Nutr., <b>135<\/b>, 2503-2506.","DOI":"10.1093\/jn\/135.11.2503"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Jump, D.B., Depner, C.M., Tripathy, S. and Lytle, K.A. (2015): Potential for dietary \u03c9-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer. Adv. Nutr., <b>6<\/b>, 694-702.","DOI":"10.3945\/an.115.009423"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J.M. and Gonzalez, F.J. (2007): Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis, <b>28<\/b>, 940-946.","DOI":"10.1093\/carcin\/bgl249"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kir, S., Beddow, S.A., Samuel, V.T., Miller, P., Previs, S.F., Suino-Powell, K., Xu, H.E., Shulman, G.I., Kliewer, S.A. and Mangelsdorf, D.J. (2011): FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science, <b>331<\/b>, 1621-1624.","DOI":"10.1126\/science.1198363"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kitada, H., Miyata, M., Nakamura, T., Tozawa, A., Honma, W., Shimada, M., Nagata, K., Sinal, C.J., Guo, G.L., Gonzalez, F.J. and Yamazoe, Y. (2003): Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J. Biol. Chem., <b>278<\/b>, 17838-17844.","DOI":"10.1074\/jbc.M210634200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Kliewer, S.A. and Mangelsdorf, D.J. (2015): Bile Acids as Hormones: The FXR-FGF15\/19 Pathway. Dig. Dis., <b>33<\/b>, 327-331.","DOI":"10.1159\/000371670"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Liu, N., Meng, Z., Lou, G., Zhou, W., Wang, X., Zhang, Y., Zhang, L., Liu, X., Yen, Y., Lai, L., Forman, B.M., Xu, Z., Xu, R. and Huang, W. (2012): Hepatocarcinogenesis in FXR-\/- mice mimics human HCC progression that operates through HNF1\u03b1 regulation of FXR expression. Mol. Endocrinol., <b>26<\/b>, 775-785.","DOI":"10.1210\/me.2011-1383"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Lo, C.J., Chiu, K.C., Fu, M., Lo, R. and Helton, S. (1999): Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J. Surg. Res., <b>82<\/b>, 216-221.","DOI":"10.1006\/jsre.1998.5524"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Makishima, M., Okamoto, A.Y., Repa, J.J., Tu, H., Learned, R.M., Luk, A., Hull, M.V., Lustig, K.D., Mangelsdorf, D.J. and Shan, B. (1999): Identification of a nuclear receptor for bile acids. Science, <b>284<\/b>, 1362-1365.","DOI":"10.1126\/science.284.5418.1362"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Mater, M.K., Thelen, A.P., Pan, D.A. and Jump, D.B. (1999): Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J. Biol. Chem., <b>274<\/b>, 32725-32732.","DOI":"10.1074\/jbc.274.46.32725"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Matsubara, T., Li, F. and Gonzalez, F.J. (2013): FXR signaling in the enterohepatic system. Mol. Cell Endocrinol., <b>368<\/b>, 17-29.","DOI":"10.1016\/j.mce.2012.05.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Miyata, M., Kinoshita, Y., Shinno, K., Sugiura, Y. and Harada, K. (2016): Hepatic n-3\/n-6 polyunsaturated fatty acid shift improves hepatic steatosis in farnesoid X receptor-null mice. Fisheries Sci., <b>82<\/b>, 529-536.","DOI":"10.1007\/s12562-016-0984-x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Miyata, M., Nomoto, M., Sotodate, F., Mizuki, T., Hori, W., Nagayasu, M., Yokokawa, S., Ninomiya, S. and Yamazoe, Y. (2010): Possible protective role of pregnenolone-16 alpha-carbonitrile in lithocholic acid-induced hepatotoxicity through enhanced hepatic lipogenesis. Eur. J. Pharmacol., <b>636<\/b>, 145-154.","DOI":"10.1016\/j.ejphar.2010.03.022"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Miyata, M., Sakaida, Y., Matsuzawa, H., Yoshinari, K. and Yamazoe, Y. (2011): Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice. Biol. Pharm. Bull., <b>34<\/b>, 1885-1889.","DOI":"10.1248\/bpb.34.1885"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Monteiro, J., Leslie, M., Moghadasian, M.H., Arendt, B.M., Allard, J.P. and Ma, D.W. (2014): The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease. Food Funct., <b>5<\/b>, 426-435.","DOI":"10.1039\/c3fo60551e"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Nakamura, M.T., Cheon, Y., Li, Y. and Nara, T.Y. (2004): Mechanisms of regulation of gene expression by fatty acids. Lipids, <b>39<\/b>, 1077-1083.","DOI":"10.1007\/s11745-004-1333-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Nomoto, M., Miyata, M., Yin, S., Kurata, Y., Shimada, M., Yoshinari, K., Gonzalez, F.J., Suzuki, K., Shibasaki, S., Kurosawa, T. and Yamazoe, Y. (2009): Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor. Biol. Pharm. Bull., <b>32<\/b>, 172-178.","DOI":"10.1248\/bpb.32.172"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Novak, T.E., Babcock, T.A., Jho, D.H., Helton, W.S. and Espat, N.J. (2003): NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am. J. Physiol. Lung Cell Mol. Physiol., <b>284<\/b>, L84-89.","DOI":"10.1152\/ajplung.00077.2002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Parks, D.J., Blanchard, S.G., Bledsoe, R.K., Chandra, G., Consler, T.G., Kliewer, S.A., Stimmel, J.B., Willson, T.M., Zavacki, A.M., Moore, D.D. and Lehmann, J.M. (1999): Bile acids: natural ligands for an orphan nuclear receptor. Science, <b>284<\/b>, 1365-1368.","DOI":"10.1126\/science.284.5418.1365"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Postic, C. and Girard, J. (2008): Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest., <b>118<\/b>, 829-838.","DOI":"10.1172\/JCI34275"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J., Yamada, N. and Shimano, H. (2003): Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology, <b>38<\/b>, 1529-1539.","DOI":"10.1053\/jhep.2003.09028"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Sinal, C.J., Tohkin, M., Miyata, M., Ward, J.M., Lambert, G. and Gonzalez, F.J. (2000): Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis. Cell, <b>102<\/b>, 731-744.","DOI":"10.1016\/S0092-8674(00)00062-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Vanden Berghe, W., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B. and Haegeman, G. (2003): A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv. Exp. Med. Biol., <b>544<\/b>, 181-196.","DOI":"10.1007\/978-1-4419-9072-3_22"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Wang, H., Chen, J., Hollister, K., Sowers, L.C. and Forman, B.M. (1999): Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol. Cell, <b>3<\/b>, 543-553.","DOI":"10.1016\/S1097-2765(00)80348-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Wang, Y.D., Chen, W.D., Wang, M., Yu, D., Forman, B.M. and Huang, W. (2008): Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology, <b>48<\/b>, 1632-1643.","DOI":"10.1002\/hep.22519"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Houten, S.M., Wang, L., Moschetta, A., Mangelsdorf, D.J., Heyman, R.A., Moore, D.D. and Auwerx, J. (2004): Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest., <b>113<\/b>, 1408-1418.","DOI":"10.1172\/JCI21025"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Worgall, T.S., Sturley, S.L., Seo, T., Osborne, T.F. and Deckelbaum, R.J. (1998): Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem., <b>273<\/b>, 25537-25540.","DOI":"10.1074\/jbc.273.40.25537"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Xu, J., Teran-Garcia, M., Park, J.H., Nakamura, M.T. and Clarke, S.D. (2001): Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J. Biol. Chem., <b>276<\/b>, 9800-9807.","DOI":"10.1074\/jbc.M008973200"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D.D. and Huang, W. (2007): Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res., <b>67<\/b>, 863-867.","DOI":"10.1158\/0008-5472.CAN-06-1078"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Zou, A., Lehn, S., Magee, N. and Zhang, Y. (2015): New Insights into Orphan Nuclear Receptor SHP in Liver Cancer. Nucl. Receptor Res., <b>2<\/b>.","DOI":"10.11131\/2015\/101162"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Z\u00fa\u00f1iga, J., Cancino, M., Medina, F., Varela, P., Vargas, R., Tapia, G., Videla, L.A. and Fern\u00e1ndez, V. (2011): N-3 PUFA supplementation triggers PPAR-\u03b1 activation and PPAR-\u03b1\/NF-\u03baB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS One, <b>6<\/b>, e28502.","DOI":"10.1371\/journal.pone.0028502"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/6\/42_671\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T05:55:54Z","timestamp":1570341354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/6\/42_671\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.42.671","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}